CliffBio
small molecule

RESERPINE

RESERPINE

Loss of exclusivity—loss of exclusivity
CompanyCycle Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameRESERPINE
Active ingredientRESERPINE
Strength0.1MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Cycle Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

RESERPINE patent cliff — loss of exclusivity — | CliffBio